ERG/EOG Study in AMD Patients Treated With Ranibizumab

Completed

Conditions studied: Age-Related Macular Degeneration

In brief

This is an open-label study assessing electrophysiologic testing of the retina with Electoretinogram (ERG) /Electrooculogram (EOG) tests in patients with exudative age-related macular degeneration (AMD). The standard FDA-approved treatment for wet AMD is ranibizumab (Lucentis). This study focuses on the ERG and EOG tests to evaluate retinal responses to ranibizumab treatment in AMD.

Key facts

Study ID
NCT00791427
Run by
Retina Center, Minnesota
People needed
10
Starts
2008-11-01
Expected to finish
2011-09-01
Last updated by the study team
2015-05-08

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.